Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Bridge Biotherapeutics Announces China NMPA Clearance of IND for BBT-401, a Pellino-1 Inhibitor for UC

prnasiaJanuary 05, 2020

Tag: Bridge Biotherapeutics , NMPA Clearance , BBT-401

PharmaSources Customer Service